{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:09:16Z","timestamp":1791871756984,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.radonc.2022.09.010","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T21:41:42Z","timestamp":1663623702000},"page":"39-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicity"],"prefix":"10.1016","volume":"176","author":[{"given":"Gozde","family":"Yazici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayyam","family":"Kiratli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Ozyigit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezin Yuce","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysenur","family":"Elmali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melek Tugce","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem","family":"Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Deliktas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekim","family":"Gumeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Cengiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faruk","family":"Zorlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.09.010_b0005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/OPTH.S89591","article-title":"Uveal melanoma: epidemiology, etiology, and treatment of primary disease","volume":"11","author":"Krantz","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.radonc.2022.09.010_b0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.radonc.2011.06.038","article-title":"Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results","volume":"102","author":"Muller","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.09.010_b0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/bjo.2008.142208","article-title":"Gamma knife radiosurgery for uveal melanoma: 12 years of experience","volume":"93","author":"Modorati","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.radonc.2022.09.010_b0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2017.02.017","article-title":"Stereotactic radiosurgery and fractionated stereotactic radiation therapy for the treatment of uveal melanoma","volume":"98","author":"Yazici","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.09.010_b0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00055735-199606000-00005","article-title":"New treatment modalities for uveal melanoma","volume":"7","author":"De Potter","year":"1996","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.radonc.2022.09.010_b0030","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma","volume":"124","author":"Collaborative Ocular Melanoma Study G","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.radonc.2022.09.010_b0035","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/bjo.72.7.494","article-title":"Cobalt plaque versus enucleation for uveal melanoma: comparison of survival rates","volume":"72","author":"Adams","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.radonc.2022.09.010_b0040","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0161-6420(98)99037-6","article-title":"Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy","volume":"105","author":"Augsburger","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.radonc.2022.09.010_b0045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000334401","article-title":"Comparison of clinical outcomes for patients with large choroidal melanoma after primary treatment with enucleation or proton beam radiotherapy","volume":"227","author":"Mosci","year":"2012","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.radonc.2022.09.010_b0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijrobp.2005.01.058","article-title":"Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma","volume":"63","author":"Muller","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.09.010_b0055","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.ijrobp.2006.01.005","article-title":"Optimizing LINAC-based stereotactic radiotherapy of uveal melanomas: 7 years\u2019 clinical experience","volume":"66","author":"Dieckmann","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.09.010_b0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijrobp.2011.06.1957","article-title":"Radiogenic side effects after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007","volume":"83","author":"Dunavoelgyi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.09.010_b0065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/bjophthalmol-2012-302808","article-title":"A comparison between 125Iodine brachytherapy and stereotactic radiotherapy in the management of juxtapapillary choroidal melanoma","volume":"97","author":"Krema","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.radonc.2022.09.010_b0070","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/eye.2015.109","article-title":"Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma","volume":"29","author":"Sikuade","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.radonc.2022.09.010_b0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000071345","article-title":"Tumour regression of uveal melanoma after ruthenium-106 brachytherapy or stereotactic radiotherapy with gamma knife or linear accelerator","volume":"217","author":"Georgopoulos","year":"2003","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.radonc.2022.09.010_b0080","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5114\/jcb.2017.70986","article-title":"Patterns of care and survival outcomes after treatment for uveal melanoma in the post-coms era (2004\u20132013): a surveillance, epidemiology, and end results analysis","volume":"9","author":"Rao","year":"2017","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.radonc.2022.09.010_b0085","first-page":"456","article-title":"Is it sufficient to repeat LINEAR accelerator stereotactic radiosurgery in choroidal melanoma?","volume":"117","author":"Furdova","year":"2016","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.radonc.2022.09.010_b0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000098525","article-title":"Gamma-knife-based stereotactic radiosurgery for uveal melanoma","volume":"85","author":"Fakiris","year":"2007","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.radonc.2022.09.010_b0095","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3171\/jns.2002.97.supplement_5.0635","article-title":"Leksell gamma knife treatment of uveal melanoma","volume":"97","author":"Simonova","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2022.09.010_b0100","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0161-6420(00)00150-0","article-title":"Stereotactic radiosurgery of large uveal melanomas with the gamma-knife","volume":"107","author":"Mueller","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.radonc.2022.09.010_b0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(00)00164-X","article-title":"Local tumor control and morbidity after one to three fractions of stereotactic external beam irradiation for uveal melanoma","volume":"55","author":"Zehetmayer","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.09.010_b0110","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/1754-9485.12489","article-title":"Choroidal melanoma treated with stereotactic fractionated radiotherapy and prophylactic intravitreal bevacizumab: The Dunedin Hospital experience","volume":"60","author":"Haji Mohd Yasin","year":"2016","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.09.010_b0115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/bjophthalmol-2013-304031","article-title":"Local tumour control and eye preservation after gamma-knife radiosurgery of choroidal melanomas","volume":"98","author":"Wackernagel","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.radonc.2022.09.010_b0120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.radonc.2013.08.004","article-title":"Hypofractionated stereotactic photon radiotherapy of posteriorly located choroidal melanoma with five fractions at ten Gy\u2013clinical results after six years of experience","volume":"108","author":"Dunavoelgyi","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.09.010_b0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0167-8140(02)00345-6","article-title":"LINAC based stereotactic radiotherapy of uveal melanoma: 4 years clinical experience","volume":"67","author":"Dieckmann","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.09.010_b0130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/jamaophthalmol.2013.697","article-title":"Retrospective evaluation of patients with uveal melanoma treated by stereotactic radiosurgery with and without tumor resection","volume":"131","author":"Suesskind","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.radonc.2022.09.010_b0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/COC.0000000000000775","article-title":"Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma","volume":"44","author":"Kosydar","year":"2021","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.09.010_b0140","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0360-3016(02)04200-1","article-title":"Eye retention after proton beam radiotherapy for uveal melanoma","volume":"55","author":"Egger","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.09.010_b0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/0284186X.2020.1820572","article-title":"Hypofractionated stereotactic photon radiotherapy of choroidal melanoma: 20-year experience","volume":"60","author":"Eibenberger","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2022.09.010_b0150","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13014-018-1088-9","article-title":"Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma","volume":"13","author":"Akbaba","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.09.010_b0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0002-9394(99)00315-3","article-title":"Intraoperative echographic localization of iodine-125 episcleral plaque for brachytherapy of choroidal melanoma","volume":"129","author":"Tabandeh","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.radonc.2022.09.010_b0160","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ijrobp.2013.12.014","article-title":"Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy","volume":"88","author":"Badiyan","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.09.010_b0165","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0161-6420(99)90456-6","article-title":"Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma","volume":"106","author":"Wilson","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.radonc.2022.09.010_b0170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.brachy.2009.03.189","article-title":"<sup>125<\/sup>I episcleral plaque brachytherapy in the treatment of choroidal melanoma: A single-institution experience in Spain","volume":"8","author":"Correa","year":"2009","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2022.09.010_b0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13014-020-01621-4","article-title":"106Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma","volume":"15","author":"Jiang","year":"2020","journal-title":"Rad Oncol"},{"key":"10.1016\/j.radonc.2022.09.010_b0180","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0161-6420(02)01277-0","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.radonc.2022.09.010_b0185","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0360-3016(00)01430-9","article-title":"Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality","volume":"49","author":"Fuss","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.09.010_b0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijrobp.2014.01.026","article-title":"Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes","volume":"89","author":"Perez","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.09.010_b0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000455872","article-title":"Iodine-125 Brachytherapy for Uveal Melanoma: A Systematic Review of Radiation Dose","volume":"3","author":"Echegaray","year":"2017","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.radonc.2022.09.010_b0200","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000501971","article-title":"Gamma Knife radiosurgery for uveal melanoma: A retrospective review of clinical complications in a Tertiary Referral Center","volume":"6","author":"Modorati","year":"2020","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.radonc.2022.09.010_b0205","first-page":"3","article-title":"Radiation maculopathy after one-day session stereotactic radiosurgery in patients with ciliary body and choroidal melanoma","volume":"75","author":"Zahorjanova","year":"2019","journal-title":"Cesk Slov Oftalmol"},{"key":"10.1016\/j.radonc.2022.09.010_b0210","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bjophthalmol-2017-310801","article-title":"Predictors of radio-induced visual impairment after radiosurgery for uveal melanoma","volume":"102","author":"Gigliotti","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.radonc.2022.09.010_b0215","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.radonc.2013.08.018","article-title":"Dose-response of critical structures in the posterior eye segment to hypofractioned stereotactic photon radiotherapy of choroidal melanoma","volume":"108","author":"Dunavoelgyi","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.09.010_b0220","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4149\/neo_2018_171209N808","article-title":"Uveal melanoma survival rates after single dose stereotactic radiosurgery","volume":"65","author":"Furdova","year":"2018","journal-title":"Neoplasma"},{"key":"10.1016\/j.radonc.2022.09.010_b0225","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/aos.12731","article-title":"Risk factors associated with secondary enucleation after fractionated stereotactic radiotherapy in uveal melanoma","volume":"93","author":"van den Bosch","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.radonc.2022.09.010_b0230","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00417-012-2144-z","article-title":"Gamma-knife-based stereotactic radiosurgery for medium- and large-sized posterior uveal melanoma","volume":"251","author":"Sarici","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.radonc.2022.09.010_b0235","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/j.prro.2018.06.005","article-title":"Effect of daily and every other day stereotactic body radiation therapy schedules on treatment-related fatigue in patients with hepatocellular carcinoma","volume":"9","author":"Hasan","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.09.010_b0240","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1748-717X-8-242","article-title":"A simple strategy to decrease fatal carotid blowout syndrome after stereotactic body reirradiaton for recurrent head and neck cancers","volume":"8","author":"Yazici","year":"2013","journal-title":"Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022042773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022042773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:22:31Z","timestamp":1759123351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022042773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":48,"alternative-id":["S0167814022042773"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.09.010","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicity","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}